Correlation Between Anebulo Pharmaceuticals and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Innate Pharma, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Innate Pharma.
Diversification Opportunities for Anebulo Pharmaceuticals and Innate Pharma
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Anebulo and Innate is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Innate Pharma go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Innate Pharma
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Innate Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.27 times less risky than Innate Pharma. The stock trades about -0.18 of its potential returns per unit of risk. The Innate Pharma is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 171.00 in Innate Pharma on August 28, 2024 and sell it today you would lose (21.00) from holding Innate Pharma or give up 12.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Innate Pharma
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Innate Pharma |
Anebulo Pharmaceuticals and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Innate Pharma
The main advantage of trading using opposite Anebulo Pharmaceuticals and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals | Anebulo Pharmaceuticals vs. Seres Therapeutics |
| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |